DAXX and hepatocellular carcinoma: Specific MAPK signaling in the HCC component was detected with overexpression of DAXX, FGFR3, and FLNC (approximately 2-fold, 8-fold, and 3-fold overexpression, respectively; Figure 4(b) and Supplemental Table S3).